With respect to canonical CAF markers, one theme in breast cancer CAFs from scRNA seq data includes use of these markers to stratify populations, such as by PDPN versus FSP (Friedman et al., 2020) or Fap/Fsp/Acta2/Pdgfrb status (Costa et al., 2018). This evidence concerns the gene FAP and breast carcinoma.